No abstract available
MeSH terms
-
Antineoplastic Agents / standards*
-
Antineoplastic Agents / therapeutic use
-
Clinical Trials, Phase II as Topic
-
Clinical Trials, Phase III as Topic
-
Combined Modality Therapy
-
Dose-Response Relationship, Drug
-
Forecasting
-
Humans
-
Immunotherapy / standards*
-
Lymphoma, Mantle-Cell / therapy*
-
Radiotherapy / standards*
-
Randomized Controlled Trials as Topic
-
Stem Cell Transplantation